SCHEMBL13401550

SCHEMBL13401550

CC(=O)NC(CN1CCC(=O)C=CC1=O)CN1CCC(=O)C=CC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12721088 0.67 MGLL (0.38) —
SCHEMBL8025929 0.56 SMN1; SMN2 (0.51) —
SCHEMBL11912416 0.55 PLA2G2C (0.38) —
SCHEMBL21761328 0.55 OPRM1 (0.33) —
SCHEMBL10106996 0.55 ALDH1A1 (0.38) —
SCHEMBL5394039 0.54 SIGMAR1 (0.42) —
SCHEMBL10654652 0.54 SMN1; SMN2 (0.56) —
SCHEMBL422585 0.54 — —
SCHEMBL1861994 0.54 — —
SCHEMBL12795884 0.54 L3MBTL1 (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100092483-A1 Compositions monovalent for CD40L binding and methods of use DOMANTIS LIMITED 2010-04-15 — — US disclosed
Send feedback